bf/NASDAQ:VRDN_icon.jpeg

NASDAQ:VRDN

Viridian Therapeutics, Inc.

  • Stock

USD

Last Close

14.63

17/05 20:00

Market Cap

1.05B

Beta: 0.98

Volume Today

1.09M

Avg: 548.41K

PE Ratio

−3.84

PFCF: −5.44

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-2.16M
-
-7.89M
265.33%
-11.33M
43.57%
-12.67M
11.88%
-26.51M
109.18%
-32.70M
23.35%
-41.87M
28.04%
-110.72M
164.41%
-79.41M
28.27%
-129.87M
63.54%
-237.73M
83.05%
depreciation and amortization
148.31K
-
144K
2.91%
184K
27.78%
189K
2.72%
308K
62.96%
281K
8.77%
288K
2.49%
239K
17.01%
120K
49.79%
255K
112.50%
522K
104.71%
deferred income tax
177K
-
868K
-
-416K
-
-432K
3.85%
56K
112.96%
1.04M
1,753.57%
12.04M
-
stock based compensation
4.30M
-
3.02M
29.85%
2.11M
29.98%
2.41M
14.12%
3.68M
52.72%
3.97M
7.91%
3.65M
8.19%
14.46M
296.84%
19.77M
36.64%
67.17M
239.85%
change in working capital
-649.45K
-
105K
116.17%
1.10M
946.67%
2.18M
98.54%
-4.47M
304.67%
1.94M
143.42%
1.65M
14.85%
4.43M
168.14%
1.72M
61.06%
15.96M
825.87%
-9.43M
159.05%
accounts receivables
201.59K
-
-271K
234.43%
694K
356.09%
-130K
118.73%
-1.44M
1,004.62%
1.43M
199.72%
-84K
105.87%
99K
217.86%
-451K
555.56%
349K
177.38%
inventory
-187.10K
-
178K
195.14%
-8K
104.49%
123K
1,637.50%
-50.90M
41,482.11%
-57.80M
13.55%
451K
-
-349K
177.38%
accounts payables
-279.73K
-
383K
236.92%
633K
65.27%
2.03M
220.38%
-101K
104.98%
-335K
231.68%
525K
256.72%
-426K
181.14%
1.66M
488.50%
11.52M
596.31%
-12.04M
204.48%
other working capital
-384.20K
-
-185K
51.85%
-220K
18.92%
161K
173.18%
47.97M
29,695.65%
58.64M
22.23%
1.21M
97.94%
4.75M
292.89%
69K
98.55%
4.44M
6,331.88%
2.62M
41.08%
other non cash items
1.49M
-
953K
36.17%
132K
86.15%
93K
29.55%
94K
1.08%
376K
300%
340K
9.57%
72.57M
21,243.82%
7.49M
89.69%
54K
99.28%
-16.75M
31,109.26%
net cash provided by operating activities
-1.17M
-
-2.21M
89.50%
-6.90M
211.70%
-7.23M
4.83%
-28.17M
289.53%
-26.84M
4.70%
-36.06M
34.32%
-29.78M
17.41%
-54.58M
83.29%
-93.84M
71.92%
-184.17M
96.26%
investments in property plant and equipment
-4.77K
-
-266K
5,477.69%
-123K
53.76%
-3K
97.56%
-246K
8,100%
-445K
80.89%
-84K
81.12%
-42K
50%
-338K
704.76%
-797K
135.80%
-898K
12.67%
acquisitions net
1.28M
-
-28.31M
-
29.37M
203.75%
79K
99.73%
114.33M
144,620.25%
purchases of investments
-62.46M
-
-32.69M
47.66%
-81.81M
150.25%
-188.43M
130.34%
-223.26M
18.49%
-407.88M
82.69%
sales maturities of investments
33M
-
61M
84.85%
2M
96.72%
114.40M
5,619.90%
108.94M
4.78%
314.53M
188.73%
other investing activites
10.45K
-
-8K
176.53%
28K
450%
28.31M
-
-3K
100.01%
-114.33M
-
net cash used for investing activites
5.68K
-
-274K
4,919.70%
-95K
65.33%
-3K
96.84%
1.03M
34,566.67%
-29.91M
2,992.36%
28.23M
194.38%
-50.48M
278.85%
-74.29M
47.17%
-115.13M
54.96%
-94.25M
18.13%
debt repayment
-10.52M
-
-42K
99.60%
-76K
80.95%
-84K
10.53%
-4.67M
5,455.95%
-2.33M
-
-10.29M
341.19%
-446K
-
-14.49M
3,147.98%
common stock issued
6.64M
-
13.10M
97.10%
48.56M
-
44.53M
8.31%
2.28M
94.87%
25.10M
999.61%
114.24M
355.07%
291.87M
155.49%
125.07M
57.15%
common stock repurchased
-363K
-
-173K
52.34%
-44K
-
183K
-
580K
216.94%
dividends paid
-285K
-
-44K
-
-14.49M
-
other financing activites
12.07M
-
795K
93.41%
50K
93.71%
8.57M
-
-2.61M
130.48%
120K
104.59%
86.59M
72,056.67%
11.03M
87.26%
30.63M
177.65%
128.99M
321.09%
net cash used provided by financing activities
1.26M
-
7.40M
487.57%
12.71M
71.77%
-257K
102.02%
52.47M
20,516.34%
41.92M
20.11%
70K
99.83%
101.31M
144,630%
125.28M
23.65%
322.24M
157.23%
225.67M
29.97%
effect of forex changes on cash
net change in cash
96.81K
-
4.91M
4,971.58%
5.71M
16.35%
-7.49M
231.12%
25.34M
438.23%
-14.84M
158.55%
-7.76M
47.69%
21.05M
371.28%
-3.60M
117.09%
113.28M
3,248.42%
-52.75M
146.57%
cash at beginning of period
112.53K
-
209K
85.72%
5.12M
2,349.28%
10.83M
111.60%
22.10M
104.06%
47.44M
114.63%
32.61M
31.27%
24.85M
23.80%
45.90M
84.73%
42.30M
7.84%
155.58M
267.81%
cash at end of period
209.35K
-
5.12M
2,345.21%
10.83M
111.60%
3.34M
69.16%
47.44M
1,319.96%
32.61M
31.27%
24.85M
23.80%
45.90M
84.73%
42.30M
7.84%
155.58M
267.81%
102.83M
33.91%
operating cash flow
-1.17M
-
-2.21M
89.50%
-6.90M
211.70%
-7.23M
4.83%
-28.17M
289.53%
-26.84M
4.70%
-36.06M
34.32%
-29.78M
17.41%
-54.58M
83.29%
-93.84M
71.92%
-184.17M
96.26%
capital expenditure
-4.77K
-
-266K
5,477.69%
-123K
53.76%
-3K
97.56%
-246K
8,100%
-445K
80.89%
-84K
81.12%
-42K
50%
-338K
704.76%
-797K
135.80%
-898K
12.67%
free cash flow
-1.17M
-
-2.48M
111.42%
-7.02M
183.22%
-7.23M
3.03%
-28.41M
292.77%
-27.29M
3.96%
-36.14M
32.43%
-29.82M
17.48%
-54.92M
84.16%
-94.64M
72.32%
-185.07M
95.56%

All numbers in USD (except ratios and percentages)